Sort
326,823 grants matching “clinical trial”
Bacterial and Host Heterogeneity in TB latency, persistence and progression
$2,722,689David Alland · Rutgers Biomedical And Health Sciences · U19 · FY2025 · AI
Chemoprevention of Lung Cancer
$2,721,020University Of Cincinnati · P01 · FY2005 · CA
Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination
$2,720,994Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2019 · AI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,720,678Barry Coller · Rockefeller University · UL1 · FY2009 · RR
Vanderbilt HIV Clinical Trials Unit (CTU)
$2,720,209David W Haas · Vanderbilt University Medical Center · UM1 · FY2025 · AI
UNC MACS/WIHS Combined Cohort Study Clinical Research Site
$2,720,100Michelle Floris-Moore · Univ Of North Carolina Chapel Hill · U01 · FY2023 · HL
Leadership Center Administration
$2,720,052Robert A Wood · Johns Hopkins University · UM2 · FY2022 · AI
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$2,719,866Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Center for Research Improving Treatment of Drug Abuse
$2,719,701University Of Pennsylvania · P60 · FY2005 · DA
Development of a Vaccine for HIVAIDS: Humoral Immunity
$2,718,739Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Gene Therapy for Leber Congenital Amaurosis
$2,718,463University Of Florida · U10 · FY2004 · EY
Emergency Department Safety Assessment and Follow-Up Evaluation (EDSAFE) Trial
$2,717,641Edwin D Boudreaux · Univ Of Massachusetts Med Sch Worcester · U01 · FY2012 · MH
Development of a COVID-19 Vaccine
$2,717,614Steven Reed · Hdt Bio Corporation · N01 · FY2022 · AI
Molecular profiling and immunomodulatory interventions
$2,717,163Abraham Na Shaked · University Of Pennsylvania · U01 · FY2008 · AI
ADalimumab Vs. conventional ImmunoSupprEssion for uveitis(ADVISE) Trial
$2,717,020Janet T. Holbrook · Johns Hopkins University · UG1 · FY2020 · EY
Data Coordinating Center for Organ Transplant Clinical *
$2,716,690Ppd, Inc. · U01 · FY2005 · AI
Systems-Based Predictions of Responses to Cancer Therapy
$2,716,509University Of Calif-Lawrenc Berkeley Lab · U54 · FY2005 · CA
Vanderbilt HIV Clinical Trials Unit
$2,716,438David W Haas · Vanderbilt University · UM1 · FY2014 · AI
Clot Lysis: Evaluating Accelerated Resolution of IVH Phase III (CLEAR III)
$2,716,322Daniel F Hanley · Johns Hopkins University · U01 · FY2009 · NS
Clot Lysis: Evaluating Accelerated Resolution of IVH Phase III (CLEAR III
$2,716,322Daniel F Hanley · Johns Hopkins University · U01 · FY2009 · NS
Delirium, Dementia, and the Vulnerable Brain: An Integrative Approach
$2,716,296Sharon K Inouye · Hebrew Rehabilitation Center For Aged · P01 · FY2022 · AG
SPORE in Prostate Cancer
$2,715,008Peter T Scardino · Sloan-Kettering Inst Can Research · P50 · FY2008 · CA
Harnessing CD4+ T cell responses for long-term protective immunity against HIV
$2,714,796Rafi Ahmed · Scripps Research Institute, The · UM1 · FY2018 · AI
Therapeutic Targeting of Vascular Subphenotypes of Lung Disease
$2,714,385Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · P01 · FY2018 · HL
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,714,276Thomas P. Shanley · University Of Michigan At Ann Arbor · UL1 · FY2011 · RR